Unicycive Therapeutics, Inc. , a biotechnology company, engages in developing novel therapies for kidney diseases in the United States.
Unicycive Therapeutics stock last closed at $1.07, down 1.83% from the previous day, and has decreased 37.06% in one year. It has underperformed other stocks in the Biotechnology industry by 0.12 percentage points. Unicycive Therapeutics stock is currently +127.66% from its 52-week low of $0.47, and -41.31% from its 52-week high of $1.82.
At the moment, there are 34.76M UNCY shares outstanding. The market cap of UNCY is $37.19M. In the last 24 hours, 226,754 UNCY shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy UNCY shares.
In our opinion, eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your purchase of stock by creating an account with eToro today.
Open eToro AccountNow that you've selected your brokerage, you need to fill out some personal details so you are able to invest in UNCY today.
Now that you have finished signing up on our top ranked stock market app, you can securely and quickly fund your account:
Check out the tutorial below if you need help transferring funds into your investment account.
After you have identified the best place to buy Unicycive Therapeutics stock, it's critical to analyze their stock prior to buying, so you can comprehend the risk as well as the upside.
WallStreetZen was designed to help average investors do more in-depth fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on UNCY's stock page.
You can use a variety of different financial metrics, analyses, models, and charts to gauge UNCY's fair value.
You can do more valuation research on UNCY's stock here.
Out of 4 Equities analysts who give ratings on UNCY, the consensus analyst rating on UNCY is a Strong Buy
Please keep in mind that analyst ratings are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are saying on the Unicycive Therapeutics stock forecast page.
Over the past year, insiders at UNCY have not bought or sold any shares.
Learn more about who owns UNCY shares here.
No, Unicycive Therapeutics doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
You have two primary types of orders:
Hit the Open button and your broker will place your order.
If you need additional info about investing in stocks on eToro, watch the helpful video below:
Now that you own some UNCY shares, you'll want to stay up-to-date on your new investment.
Create a watchlist to keep tabs on your UNCY stock.
To reiterate, here are the 6 steps to buy stock in Unicycive Therapeutics:
If you require a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you would like to keep an eye on your new investment in Unicycive Therapeutics, create your watchlist below.